Vanguard Group’s Jasper Therapeutics JSPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.47M | Sell |
624,597
-54,855
| -8% | -$304K | ﹤0.01% | 3333 |
|
|
2025
Q1 | $2.92M | Sell |
679,452
-30,032
| -4% | -$129K | ﹤0.01% | 3358 |
|
|
2024
Q4 | $15.2M | Buy |
709,484
+15,059
| +2% | +$322K | ﹤0.01% | 2730 |
|
|
2024
Q3 | $13.1M | Buy |
694,425
+4,366
| +0.6% | +$82.1K | ﹤0.01% | 2820 |
|
|
2024
Q2 | $15.7M | Buy |
690,059
+77,314
| +13% | +$1.76M | ﹤0.01% | 2689 |
|
|
2024
Q1 | $18M | Sell |
612,745
-3,480,213
| -85% | -$102M | ﹤0.01% | 2655 |
|
|
2023
Q4 | $3.23M | Buy |
4,092,958
+300,000
| +8% | +$237K | ﹤0.01% | 3436 |
|
|
2023
Q3 | $2.66M | Buy |
3,792,958
+104,600
| +3% | +$73.2K | ﹤0.01% | 3491 |
|
|
2023
Q2 | $5.05M | Sell |
3,688,358
-37,789
| -1% | -$51.8K | ﹤0.01% | 3293 |
|
|
2023
Q1 | $6.74M | Buy |
3,726,147
+3,195,709
| +602% | +$5.78M | ﹤0.01% | 3163 |
|
|
2022
Q4 | $256K | Buy |
530,438
+318
| +0.1% | +$154 | ﹤0.01% | 4254 |
|
|
2022
Q3 | $418K | Buy |
530,120
+49,559
| +10% | +$39.1K | ﹤0.01% | 4263 |
|
|
2022
Q2 | $928K | Buy |
480,561
+2,737
| +0.6% | +$5.29K | ﹤0.01% | 4112 |
|
|
2022
Q1 | $1.7M | Sell |
477,824
-5,679
| -1% | -$20.2K | ﹤0.01% | 4023 |
|
|
2021
Q4 | $3.8M | Buy |
+483,503
| New | +$3.8M | ﹤0.01% | 3766 |
|